This study provides clinical evidence of involvement of NLRP3 inflammasome in pathology of NEC and indicates that SHMOs prevents over-activation of TLR4/NF-κB/NLRP3 signaling pathway (Fig. 4), thereby protecting newborn rats and epithelial cells from inflammatory damages. The gene discussed is NLRP3; the disease is necrotizing enterocolitis.